The elimination of Hepatitis C as a global public health threat

消除丙型肝炎这一全球公共卫生威胁

• 批准号: nhmrc : GNT1132902
• 负责人: Prof Alexander Thompson
• 金额: $ 700.15万
• 依托单位国家: 澳大利亚
• 项目类别: Programs
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/elimination-hepatitis-c-health-threat/1347861
• 关键词: elimination; Hepatitis; global; public; health

In Australia over 230,000 people live with chronic HCV infection, with an estimated annual health care cost of over > $6.5 billion if left untreated. New highly effective HCV medications - direct acting antivirals (DAAs) have a cure rate of > 90%. DAAs will revolutionise HCV care - we can now stop HCV related deaths and transmission making HCV elimination possible. This Program Grant will directly contribute to the global response to HCV elimination and Australia achieving elimination by 2030.

在澳大利亚，超过23万人患有慢性丙型肝炎病毒感染，如果不治疗，估计每年的医疗费用超过65亿美元。新的高效丙型肝炎病毒药物-直接作用抗病毒药物(DAA)的治愈率为90%。DaaS将使丙型肝炎病毒治疗发生革命性变化--我们现在可以阻止丙型肝炎病毒相关的死亡和传播，从而使消除丙型肝炎病毒成为可能。这项计划赠款将直接为全球消除丙型肝炎做出贡献，并使澳大利亚在2030年前实现消除丙型肝炎。